Bayer AG Sponsored ADRBayer AG Sponsored ADRBayer AG Sponsored ADR

Bayer AG Sponsored ADR

No trades
See on Supercharts

Key facts today


On September 2, 2025, Bayer announced that Silchester International Investors LLP surpassed the 3% voting rights threshold as of August 29, 2025, per German Securities Trading Act.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪27.37 B‬EUR
−0.823EUR
‪−2.67 B‬EUR
‪48.70 B‬EUR
‪3.93 B‬
Beta (1Y)
0.30

About Bayer AG


CEO
William N. Anderson
Website
Headquarters
Leverkusen
Founded
1952
ISIN
US0727303028
FIGI
BBG000BMYJL6
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Check out other big names from the same industry as BAYA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BAYZ5705354
Bayer US Finance LLC 6.5% 21-NOV-2033
Yield to maturity
Maturity date
Nov 21, 2033
BAYZ4646644
Bayer US Finance II LLC 4.25% 15-DEC-2025
Yield to maturity
Maturity date
Dec 15, 2025
BAYZ4140709
Monsanto Company 4.2% 15-JUL-2034
Yield to maturity
Maturity date
Jul 15, 2034
BAYZ3875861
Monsanto Company 3.6% 15-JUL-2042
Yield to maturity
Maturity date
Jul 15, 2042
BAYZ4663164
Bayer US Finance II LLC 4.7% 15-JUL-2064
Yield to maturity
Maturity date
Jul 15, 2064
BAYZ4790623
Bayer US Finance II LLC 5.875% 15-APR-2038
Yield to maturity
Maturity date
Apr 15, 2038
BAYZ4646647
Bayer US Finance II LLC 4.875% 25-JUN-2048
Yield to maturity
Maturity date
Jun 25, 2048
BAYZ4646646
Bayer US Finance II LLC 4.625% 25-JUN-2038
Yield to maturity
Maturity date
Jun 25, 2038
BAYZ3949796
Conceptus, Inc. 5.0% 15-DEC-2031
Yield to maturity
Maturity date
Dec 15, 2031
BAYZ5705348
Bayer US Finance LLC 6.125% 21-NOV-2026
Yield to maturity
Maturity date
Nov 21, 2026
BAYZ4841297
Bayer US Finance II LLC 5.5% 30-JUL-2035
Yield to maturity
Maturity date
Jul 30, 2035

See all BAYA bonds 

Curated watchlists where BAYA is featured.